Your session is about to expire
← Back to Search
Atomic Magnetometer Brain Imaging for Epilepsy
N/A
Recruiting
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day (during the brain scan)
Awards & highlights
Study Summary
This trial will help researchers learn if an atomic magnetometer can be used for brain imaging, and if it is as effective as the current method which uses a SQUID-based cryogenic sensor.
Who is the study for?
This trial is for adults aged 18-70 with epilepsy, referred through the clinical MEG program. It's not for pregnant women, those unable to consent, people with neurological disorders other than epilepsy or who can't lie still during recording, and anyone with metal implants that could interfere with sensor readings.Check my eligibility
What is being tested?
The study tests a new brain imaging device using OPM sensors against the traditional SQUID sensors in Magnetoencephalography (MEG). The goal is to see if OPMs offer a non-invasive way to monitor brain activity at room temperature effectively.See study design
What are the potential side effects?
Since this trial involves non-invasive imaging techniques rather than medication or surgery, side effects are minimal. However, discomfort from lying still and potential anxiety about being in an enclosed space during scanning may occur.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day (during the brain scan)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day (during the brain scan)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evoked and Induced MEG with OPM and SQUID sensors in healthy controls
Spontaneous MEG with OPM and SQUID sensors in patients with epilepsy
Trial Design
2Treatment groups
Experimental Treatment
Group I: healthy adultsExperimental Treatment2 Interventions
Any adult, who is at least eighteen (18-70) years old.
Group II: Patients with intractable epilepsyExperimental Treatment2 Interventions
Any clinical patient referred to us via the clinical MEG program, and who is at least eighteen (18-70) years old.
Find a Location
Who is running the clinical trial?
University of Colorado, BoulderOTHER
119 Previous Clinical Trials
29,154 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,486 Total Patients Enrolled
6 Trials studying Epilepsy
1,202 Patients Enrolled for Epilepsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of conditions that affect the brain and nervous system, like epilepsy or Parkinson's disease.I am between 18 and 70 years old.I cannot give informed consent on my own.I cannot stay still for long periods.You have a lot of metal or magnetic items in or close to your body that could interfere with the study measurements, like metal implants or pacemakers.I am between 18 and 70 years old and was referred through the clinical MEG program.
Research Study Groups:
This trial has the following groups:- Group 1: Patients with intractable epilepsy
- Group 2: healthy adults
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there plans to increase the number of people enrolled in this clinical trial?
"The listings on clinicaltrials.gov show that this clinical trial is open and actively recruiting patients. The trial was first posted on 3/1/2021 and was updated on 6/21/2021. The study needs 40 patients from 1 site."
Answered by AI
Are people of retirement age eligible for this test program?
"This trial is only for adult patients that fall within the age range of 18 to 70 years old. There are 125 other clinical trials that young patients can enroll in and 187 for senior citizens."
Answered by AI
How can I join this medical study?
"Up to 40 individuals, aged 18-70, who suffer from aura are being admitted into this clinical trial. Additionally, potential participants must meet the following requirements: Project B: Any clinical patient referred to us via the clinical MEG program, and who is at least eighteen (18 - 70) years old., Project A: Any adult subject, who is at least eighteen (18 - 70) years old."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger